Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

EXOZYMES INC. (EXOZ)

$4.71 +0.21% NASDAQ: EXOZ · 15-min delayed
  • MONROVIA, California
  • Public · NASDAQ: EXOZ
  • 32 employees
$79.2MMarket cap
$70.1KRevenue · FY2023
-$9.2MNet income
32Employees
EXOZNASDAQ
2024IPO

About EXOZYMES INC.

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2023
$70.1K
Net income
-$9.2M
Total assets
$6.0M
Market cap
$79.2M

Source: SEC EDGAR · updated Jun 7, 2026

FY 2025

Financial statements

Income statement

Operating income
-$9.7M
Net income
-$9.2M
EPS (basic)
$-1.09
EPS (diluted)
$-1.09

Balance sheet

Total assets
$6.0M
Current assets
$3.9M
Total liabilities
$2.6M
Current liabilities
$1.6M
Shareholders’ equity
$3.4M

Cash flow

Operating cash flow
-$6.5M
Investing cash flow
-$150.2K
Financing cash flow
-$27.7K
Net cash flow
-$6.7M

Statements via Polygon.io (SEC filings)

NASDAQ: EXOZ
$4.71 +0.21%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.70 $16.50

52-week range

Market cap
$79.2M
EPS (diluted)
$-1.09
Shares outstanding
16.8M
Open
Day range
Prev close
Volume
IPO date
Nov 13, 2024

Exozymes Inc. (EXOZ) Stock Price

  • Reported a net loss of $9.2M in FY2023.
  • Trading 71% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review EXOZYMES INC..

Write a review
FAQ

Exozymes Inc.: frequently asked questions

Is Exozymes Inc. an American company?

Exozymes Inc. is a US-based company headquartered in Monrovia, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Exozymes Inc. headquartered?

Exozymes Inc. is headquartered in Monrovia, California, United States.

Is Exozymes Inc. publicly traded?

Yes — Exozymes Inc. is a publicly traded company. Its stock trades under the ticker symbol EXOZ on the NASDAQ.

What does Exozymes Inc. do?

Exozymes Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →